Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Pancreatic Ductal Adenocarcinoma 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Leukemia 1 IDH1 Mutation Myeloid Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Chondrosarcoma 1 Anemia, Refractory, with Excess of Blasts 1 AML 1

Interventions

ivosidenib 1 Magnesium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × AML × ivosidenib × Clear all

NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting

AML

Data powered by HemOnc (CC BY 4.0) Colophon ⚡